RNAi Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063244
  • May 2021
  • Biotechnology
  • 129 Pages
The global RNAi Technologies market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the RNAi Technologies market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global RNAi Technologies market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of RNAi Technologies market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, QIAGEN, Invitrogen(Thermo Fisher), FilmTec Corporation, Silence Therapeutics PLC, Arcturus Therapeutics, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global RNAi Technologies market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides RNAi Technologies market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global RNAi Technologies market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the RNAi Technologies market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global RNAi Technologies Market:
The RNAi Technologies market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, QIAGEN, Invitrogen(Thermo Fisher), FilmTec Corporation, Silence Therapeutics PLC, Arcturus Therapeutics, Inc.

RNAi Technologies Market Segment Analysis:
By Type
Small interfering RNAi
Micro RNAi
Application
Drug Discovery and Development
Therapeutics
Other Applications

Geographic Coverage for RNAi Technologies Market:
The market research report on global RNAi Technologies market offers complete analysis across various regions across the world. The RNAi Technologies market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering RNAi Technologies market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America RNAi Technologies Market Value and Forecast
  • US
  • Canada
Europe RNAi Technologies Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific RNAi Technologies Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America RNAi Technologies Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa RNAi Technologies Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the RNAi Technologies market report:
  • The report provides key trends of the global RNAi Technologies market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the RNAi Technologies industry
  • The report covers all the recent developments of the RNAi Technologies market and helps to provide current industry updates
  • The report covers a detailed look over the global RNAi Technologies Industry and provides with significant actionable insights
  • The RNAi Technologies market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global RNAi Technologies market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global RNAi Technologies market
  • Comprehensive analysis of the RNAi Technologies market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the RNAi Technologies market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the RNAi Technologies market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the RNAi Technologies market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the RNAi Technologies market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the RNAi Technologies market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Alnylam Pharmaceuticals
  • Benitec Biopharma Ltd.
  • Ionis Pharmaceuticals
  • Quark Pharmaceuticals Inc.
  • RXI Pharmaceuticals
  • QIAGEN
  • Invitrogen(Thermo Fisher)
  • FilmTec Corporation
  • Silence Therapeutics PLC
  • Arcturus Therapeutics, Inc.
  • Small interfering RNAi
  • Micro RNAi
  • By ApplicationBy Applications

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global RNAi Technologies Market Snapshot
          2.1.1. Global RNAi Technologies Market By Type,2019
               2.1.1.1.Small interfering RNAi
               2.1.1.2.Micro RNAi
          2.1.2. Global RNAi Technologies Market By Application Applications,2019
               2.1.2.1.By Application ApplicationsBy Application Applicationss
          2.1.3. Global RNAi Technologies Market By End-use,2019
          2.1.4. Global RNAi Technologies Market By Geography,2019

3. Global RNAi Technologies Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global RNAi Technologies Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global RNAi Technologies Market Size (US$), By Type, 2018 – 2028

5. Global RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application Applications, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application Applications, 2020
     5.2. Global RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028

6. Global RNAi Technologies Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global RNAi Technologies Market Size (US$), By End-use, 2018 – 2028

7. Global RNAi Technologies Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America RNAi Technologies Market Analysis, 2018 – 2028 
          7.2.1. North America RNAi Technologies Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America RNAi Technologies Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028
          7.2.4. North America RNAi Technologies Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe RNAi Technologies Market Analysis, 2018 – 2028 
          7.3.1.  Europe RNAi Technologies Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe RNAi Technologies Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028
          7.3.4. Europe RNAi Technologies Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific RNAi Technologies Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific RNAi Technologies Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific RNAi Technologies Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028
          7.4.4. Asia Pacific RNAi Technologies Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America RNAi Technologies Market Analysis, 2018 – 2028 
          7.5.1.  Latin America RNAi Technologies Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America RNAi Technologies Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028
          7.5.4. Latin America RNAi Technologies Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) RNAi Technologies Market Analysis, 2018 – 2028 
          7.6.1.  MEA RNAi Technologies Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA RNAi Technologies Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA RNAi Technologies Market Size (US$), By Application Applications, 2018 – 2028
          7.6.4. MEA RNAi Technologies Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key RNAi Technologies Providers
        8.4.1 Alnylam Pharmaceuticals
                8.4.1.1 Business Description
                8.4.1.2 Alnylam Pharmaceuticals Geographic Operations
                8.4.1.3 Alnylam Pharmaceuticals Financial Information
                8.4.1.4 Alnylam Pharmaceuticals Product Positions/Portfolio
                8.4.1.5 Alnylam Pharmaceuticals Key Developments
        8.4.2 Benitec Biopharma Ltd.
                8.4.2.1 Business Description
                8.4.2.2 Benitec Biopharma Ltd. Geographic Operations
                8.4.2.3 Benitec Biopharma Ltd. Financial Information
                8.4.2.4 Benitec Biopharma Ltd. Product Positions/Portfolio
                8.4.2.5 Benitec Biopharma Ltd. Key Developments
        8.4.3 Ionis Pharmaceuticals
                8.4.3.1 Business Description
                8.4.3.2 Ionis Pharmaceuticals Geographic Operations
                8.4.3.3 Ionis Pharmaceuticals Financial Information
                8.4.3.4 Ionis Pharmaceuticals Product Positions/Portfolio
                8.4.3.5 Ionis Pharmaceuticals Key Developments
        8.4.4 Quark Pharmaceuticals Inc.
                8.4.4.1 Business Description
                8.4.4.2 Quark Pharmaceuticals Inc. Geographic Operations
                8.4.4.3 Quark Pharmaceuticals Inc. Financial Information
                8.4.4.4 Quark Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.4.5 Quark Pharmaceuticals Inc. Key Developments
        8.4.5 RXI Pharmaceuticals
                8.4.5.1 Business Description
                8.4.5.2 RXI Pharmaceuticals Geographic Operations
                8.4.5.3 RXI Pharmaceuticals Financial Information
                8.4.5.4 RXI Pharmaceuticals Product Positions/Portfolio
                8.4.5.5 RXI Pharmaceuticals Key Developments
        8.4.6 QIAGEN
                8.4.6.1 Business Description
                8.4.6.2 QIAGEN Geographic Operations
                8.4.6.3 QIAGEN Financial Information
                8.4.6.4 QIAGEN Product Positions/Portfolio
                8.4.6.5 QIAGEN Key Developments
        8.4.7 Invitrogen(Thermo Fisher)
                8.4.7.1 Business Description
                8.4.7.2 Invitrogen(Thermo Fisher) Geographic Operations
                8.4.7.3 Invitrogen(Thermo Fisher) Financial Information
                8.4.7.4 Invitrogen(Thermo Fisher) Product Positions/Portfolio
                8.4.7.5 Invitrogen(Thermo Fisher) Key Developments
        8.4.8 FilmTec Corporation
                8.4.8.1 Business Description
                8.4.8.2 FilmTec Corporation Geographic Operations
                8.4.8.3 FilmTec Corporation Financial Information
                8.4.8.4 FilmTec Corporation Product Positions/Portfolio
                8.4.8.5 FilmTec Corporation Key Developments
        8.4.9 Silence Therapeutics PLC
                8.4.9.1 Business Description
                8.4.9.2 Silence Therapeutics PLC Geographic Operations
                8.4.9.3 Silence Therapeutics PLC Financial Information
                8.4.9.4 Silence Therapeutics PLC Product Positions/Portfolio
                8.4.9.5 Silence Therapeutics PLC Key Developments
        8.4.10 Arcturus Therapeutics, Inc.
                8.4.10.1 Business Description
                8.4.10.2 Arcturus Therapeutics, Inc. Geographic Operations
                8.4.10.3 Arcturus Therapeutics, Inc. Financial Information
                8.4.10.4 Arcturus Therapeutics, Inc. Product Positions/Portfolio
                8.4.10.5 Arcturus Therapeutics, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global RNAi Technologies Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America RNAi Technologies Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America RNAi Technologies Market Revenue, By Application Applications, 2018 – 2028 (US$ Mn) 
TABLE 6 North America RNAi Technologies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe RNAi Technologies Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe RNAi Technologies Market Revenue, By Application Applications, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe RNAi Technologies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific RNAi Technologies Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific RNAi Technologies Market Revenue, By Application Applications, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific RNAi Technologies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America RNAi Technologies Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America RNAi Technologies Market Revenue, By Application Applications, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America RNAi Technologies Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA RNAi Technologies Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA RNAi Technologies Market Revenue, By Application Applications, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA RNAi Technologies Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global RNAi Technologies: Market Segmentation 
FIG. 2 Global RNAi Technologies Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global RNAi Technologies Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global RNAi Technologies Market, By Application Applications, 2019 (US$ Mn) 
FIG. 6 Global RNAi Technologies Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global RNAi Technologies Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global RNAi Technologies Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key RNAi Technologies Providers, 2019
FIG. 11 Global RNAi Technologies Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global RNAi Technologies Market Revenue Contribution, By Application Applications, 2019 & 2028 (Value %) 
FIG. 13 Global RNAi Technologies Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America RNAi Technologies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe RNAi Technologies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific RNAi Technologies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America RNAi Technologies Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA RNAi Technologies Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the RNAi Technologies market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global RNAi Technologies Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America RNAi Technologies Market Value, By Segment1, 2018 – 2028
TABLE  North America RNAi Technologies Market Value, By Segment2, 2018 – 2028
TABLE  North America RNAi Technologies Market Value, By Country, 2018 – 2028
TABLE  Europe RNAi Technologies Market Value, By Segment1, 2018 – 2028
TABLE  Europe RNAi Technologies Market Value, By Segment2, 2018 – 2028
TABLE  Europe RNAi Technologies Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific RNAi Technologies Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific RNAi Technologies Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific RNAi Technologies Market Value, By Country, 2018 – 2028
TABLE  Latin America RNAi Technologies Market Value, By Segment1, 2018 – 2028
TABLE  Latin America RNAi Technologies Market Value, By Segment2, 2018 – 2028
TABLE  Latin America RNAi Technologies Market Value, By Country, 2018 – 2028
TABLE  MEA RNAi Technologies Market Value, By Segment1, 2018 – 2028
TABLE  MEA RNAi Technologies Market Value, By Segment2, 2018 – 2028
TABLE  MEA RNAi Technologies Market Value, By Country, 2018 – 2028
TABLE  Alnylam Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Benitec Biopharma Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ionis Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quark Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  RXI Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  QIAGEN: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Invitrogen(Thermo Fisher): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  FilmTec Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Silence Therapeutics PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Arcturus Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global RNAi Technologies Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global RNAi Technologies Market, By Segment1, 2019 (US$ Mn)
FIG.  Global RNAi Technologies Market, By Segment2, 2019 (US$ Mn)
FIG.  Global RNAi Technologies Market, By Geography, 2019 (US$ Mn)
FIG.  Global RNAi Technologies Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key RNAi Technologies Providers, 2016
FIG.  Global RNAi Technologies Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Micro RNAi Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global RNAi Technologies Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  France RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  China RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  India RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA RNAi Technologies Market Value, 2018 – 2028, (US$ Mn)